Abstract
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected intravenously before ischemia and reperfusion. A δ₂-opioid receptor agonist deltorphin II significantly decreased the infarction zone/risk zone index. This effect was abolished by naltrexone, naloxone methiodide, and δ₂-opioid receptor antagonist naltriben, but not by a δ₁-opioid receptor antagonist BNTX. The infarct-limiting effect of deltorphin II was not observed after inhibition of protein kinase C or blockade of mitochondrial K(ATP) channels.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Benzophenanthridines / pharmacology
-
Benzylidene Compounds / therapeutic use
-
Decanoic Acids / pharmacology
-
Glyburide / pharmacology
-
Hydroxy Acids / pharmacology
-
Ischemic Preconditioning, Myocardial / methods*
-
Male
-
Myocardial Reperfusion Injury / metabolism
-
Naltrexone / analogs & derivatives
-
Naltrexone / therapeutic use
-
Oligopeptides / therapeutic use*
-
Potassium Channel Blockers / pharmacology
-
Potassium Channels / physiology*
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / physiology*
-
Rats
-
Rats, Wistar
-
Receptors, Opioid, delta / drug effects
-
Receptors, Opioid, delta / physiology*
Substances
-
Benzophenanthridines
-
Benzylidene Compounds
-
Decanoic Acids
-
Hydroxy Acids
-
Oligopeptides
-
Potassium Channel Blockers
-
Potassium Channels
-
Receptors, Opioid, delta
-
naltrindole benzofuran
-
deltorphin II, Ala(2)-
-
7-benzylidenenaltrexone
-
Naltrexone
-
5-hydroxydecanoic acid
-
chelerythrine
-
Protein Kinase C
-
Glyburide